Literature DB >> 12880204

Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better.

Guadalupe Nogués1, Sebastián Kadener, Paula Cramer, Manuel de la Mata, Juan Pablo Fededa, Matiás Blaustein, Anabella Srebrow, Alberto R Kornblihtt.   

Abstract

The realization that the mammalian proteomic complexity is achieved with a limited number of genes demands a better understanding of alternative splicing regulation. Promoter control of alternative splicing was originally described by our group in studies performed on the fibronectin gene. Recently, other labs extended our findings to the cystic fibrosis, CD44 and CGRP genes strongly supporting a coupling between transcription and pre-mRNA splicing. A possible mechanism that would fit in these results is that the promoter itself is responsible for recruiting splicing factors, such as SR proteins, to the site of transcription, possibly through transcription factors that bind the promoter or the transcriptional enhancers. An alternative model, discussed more extensively in this review, involves modulation of RNA pol II (pol II) elongation rate. The model is supported by findings that cis- and trans- acting factors that modulate pol II elongation on a particular template also provoke changes in the alternative splicing balance of the encoded mRNAs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880204     DOI: 10.1080/1521654031000119830

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  16 in total

1.  Alternative processing of hepatitis delta virus antigenomic RNA transcripts.

Authors:  Xingcao Nie; Jinhong Chang; John M Taylor
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 2.  RNA polymerase II transcription elongation control.

Authors:  Jiannan Guo; David H Price
Journal:  Chem Rev       Date:  2013-08-06       Impact factor: 60.622

3.  Cross talk between immunoglobulin heavy-chain transcription and RNA surveillance during B cell development.

Authors:  Aurélien Tinguely; Guillaume Chemin; Sophie Péron; Christophe Sirac; Stéphane Reynaud; Michel Cogné; Laurent Delpy
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

4.  Physiological and druggable skipping of immunoglobulin variable exons in plasma cells.

Authors:  Mohamad Omar Ashi; Nivine Srour; Jean-Marie Lambert; Anne Marchalot; Ophélie Martin; Sandrine Le Noir; Eric Pinaud; Maria Victoria Ayala; Christophe Sirac; Jérôme Saulière; Jérôme Moreaux; Michel Cogné; Laurent Delpy
Journal:  Cell Mol Immunol       Date:  2018-08-20       Impact factor: 11.530

5.  Functional coupling of RNAP II transcription to spliceosome assembly.

Authors:  Rita Das; Kobina Dufu; Ben Romney; Megan Feldt; Mark Elenko; Robin Reed
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

Review 6.  Alternative RNA splicing and cancer.

Authors:  Sali Liu; Chonghui Cheng
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-06-13       Impact factor: 9.957

7.  Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5' exons of protein 4.1R gene.

Authors:  Shu-Ching Huang; Aeri Cho; Stephanie Norton; Eva S Liu; Jennie Park; Anyu Zhou; Indira D Munagala; Alexander C Ou; Guang Yang; Amittha Wickrema; Tang K Tang; Edward J Benz
Journal:  Blood       Date:  2009-09-03       Impact factor: 22.113

8.  Analysis of a splice array experiment elucidates roles of chromatin elongation factor Spt4-5 in splicing.

Authors:  Yuanyuan Xiao; Yee H Yang; Todd A Burckin; Lily Shiue; Grant A Hartzog; Mark R Segal
Journal:  PLoS Comput Biol       Date:  2005-09-16       Impact factor: 4.475

Review 9.  Alternative pre-mRNA processing regulates cell-type specific expression of the IL4l1 and NUP62 genes.

Authors:  Stefan Wiemann; Anja Kolb-Kokocinski; Annemarie Poustka
Journal:  BMC Biol       Date:  2005-07-19       Impact factor: 7.431

10.  Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.

Authors:  Serena Nicolai; Silvia Filippi; Manuela Caputo; Lubos Cipak; Juraj Gregan; Gustav Ammerer; Mattia Frontini; Daniela Willems; Giorgio Prantera; Adayabalam S Balajee; Luca Proietti-De-Santis
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.